跳至主要内容
临床试验/NCT01395082
NCT01395082已完成不适用

ACAM2000® Myopericarditis Registry

Emergent BioSolutions0 个研究点目标入组 24 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
主要终点
The number of confirmed, probable, suspected, and subclinical cases of myopericarditis, categorized by time since vaccination

研究概览

简要总结

The purpose of this registry is to study the natural history of vaccination-related myocarditis and pericarditis and to assess possible risk factors for these conditions.

Primary Objective:

  • To document the natural history of confirmed, probable, suspected, and subclinical myocarditis and pericarditis (myopericarditis) following ACAM2000® vaccination.

Other Pre-defined Objective:

  • To look for potential predictive factors for the prognosis of myopericarditis following ACAM2000® vaccination.

详细描述

All participants will have received previous vaccination with ACAM2000 but will not receive any vaccination as part of the registry. All participants enrolled in the registry will be followed for 2 up to 5 years (depending on whether there are persisting signs and symptoms of myopericarditis).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals who are current or former members of the active duty, Reserve, or National Guard, from any branch of service
  • Documented vaccination with ACAM2000® vaccine
  • Meet one of the case definitions for suspect, probable, confirmed or subclinical myopericarditis.

排除标准

  • Individuals not meeting at least one of the case definitions for myopericarditis will not be entered into the Registry.

结局指标

主要结局

The number of confirmed, probable, suspected, and subclinical cases of myopericarditis, categorized by time since vaccination

时间窗: 2 years after enrollment or after the last symptoms or positive findings

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验